Access Bio Revenue

In the year 2024, Access Bio had annual revenue of 112.46B KRW, down -67.74%. Access Bio had revenue of 29.86B in the quarter ending December 31, 2024, a decrease of -17.63%.

Revenue

112.46B

Revenue Growth

-67.74%

P/S Ratio

1.42

Revenue / Employee

1.11B

Employees

101

Market Cap

164.44B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	112.46B	-236.18B	-67.74%
Dec 31, 2023	348.64B	-685.22B	-66.28%
Dec 31, 2022	1,033.86B	528.75B	104.68%
Dec 31, 2021	505.11B	383.31B	314.71%
Dec 31, 2020	121.80B	78.74B	182.86%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,547.32B
Celltrion	3,557.30B
ALTEOGEN	102.85B
Yuhan	2,067.79B
SK Biopharmaceuticals	547.60B
HLB Co., Ltd.	51.92B
Sam Chun Dang Pharm.	210.92B
PharmaResearch	350.12B

Revenue Rankings